← Back to Clinical Trials
Recruiting Phase 2, Phase 3 NCT06568770

NCT06568770 Comparison of EOSP Between Usg Guided S-FICB vs USG Guided PENG Block in Pts Undergoing Femur Fracture Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06568770
Status Recruiting
Phase Phase 2, Phase 3
Sponsor Sahiwal medical college sahiwal
Condition Post Operative Pain
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-07-10
Primary Completion 2025-11-10

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
USG GUIDED SUPRA-INGUINAL FASCIA ILIACA BLOCKPERICAPSULAR NERVE BLOCK

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.

This trial targets 70 participants in total. It began in 2024-07-10 with a primary completion date of 2025-11-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To compare the immediate and postoperative analgesic efficacy of S-FICB and PENG block will be the objective. The use of ultrasonography in anesthesia has helped the anesthetist to see the nerve, needle and the distribution of the drug, thereby enhancing the chances of a favorable outcome of the nerve block. Grade A recommendation for an ultrasound guided approach to the peripheral nerve blocks is supported by level Ib evidence for a shortened time for the onset of sensory block, decreased performance time and lower drug doses10. Although individually both the blocks have been studied, there are only a handful of studies comparing both techniques under ultrasound guidance for making patient positioning for spinal anesthesia easy. And no local data is available comparing these blocks. So, we want to compare the analgesic efficacy of USG PENG block with USG S-FICB block in patients with fracture femur in reducing pain associated with positioning (sitting) for subarachnoid block, duration of analgesia, opioid sparing effect and complications. So that procedure with better analgesic efficacy and less complications will be included in our local guidelines as a part of multimodal analgesia.

Eligibility Criteria

Inclusion Criteria: * 1\. Both Genders (Male /Female). 2. Age between 20 years to 70 years. 3. Radiologically confirmed femur fracture. 4. ASA Class I, II, III. Exclusion Criteria: 1. Patient refusal 2. Other distracting painful pathology 3. Any contraindication to Spinal Anesthesia or peripheral nerve blocks 4. Coagulopathic disorders 5. H/O ischemic heart disease 6. Patients on opioids for chronic pain 7. Patients with significant cognitive impairment 8. Patients with no pain while sitting by themselves without any support.

Contact & Investigator

Central Contact

Dr Shajeea Asghar, MBBS

✉ shajeea55.sa@gmail.com

📞 00923217731060

Principal Investigator

Adeel Riaz, MD

STUDY DIRECTOR

Sahiwal medical college sahiwal

Frequently Asked Questions

Who can join the NCT06568770 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

What phase is the NCT06568770 trial and what does that mean for participants?

Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.

Is NCT06568770 currently recruiting?

Yes, NCT06568770 is actively recruiting participants. Contact the research team at shajeea55.sa@gmail.com for enrollment information.

Where is the NCT06568770 trial being conducted?

This trial is being conducted at Sahiwal, Pakistan.

Who is sponsoring the NCT06568770 clinical trial?

NCT06568770 is sponsored by Sahiwal medical college sahiwal. The principal investigator is Adeel Riaz, MD at Sahiwal medical college sahiwal. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology